Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Equity Ratio (2021 - 2025)

Senti Biosciences has reported Equity Ratio over the past 5 years, most recently at 0.11 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 58.38% year-over-year to 0.11; the TTM value through Dec 2025 reached 0.11, down 58.38%, while the annual FY2025 figure was 0.11, 58.38% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.11 at Senti Biosciences, down from 0.15 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.76 in Q2 2022 and troughed at 212.07 in Q1 2021.
  • A 5-year average of 10.36 and a median of 0.41 in 2025 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: surged 295.04% in 2022 and later crashed 58.38% in 2025.
  • Year by year, Equity Ratio stood at 1.15 in 2021, then surged by 161.07% to 0.7 in 2022, then fell by 20.44% to 0.56 in 2023, then crashed by 53.19% to 0.26 in 2024, then plummeted by 58.38% to 0.11 in 2025.
  • Business Quant data shows Equity Ratio for SNTI at 0.11 in Q4 2025, 0.15 in Q3 2025, and 0.36 in Q2 2025.